Advertisement

Topics

Cross-Border Enrollment of Rare Disease Patients

10:45 EDT 1 Oct 2018 | Pharma-Voice

PRA has written a new white paper on the considerations for planning and conducting global rare disease clinical trials. Rare disease trials are inherently designed to include fewer patients, are often longer in duration, and more frequently terminated than trials in more common indications. These challenges impact both sponsors and patients. A recent literature review […]

The post Cross-Border Enrollment of Rare Disease Patients appeared first on PharmaVOICE.

Original Article: Cross-Border Enrollment of Rare Disease Patients

NEXT ARTICLE

More From BioPortfolio on "Cross-Border Enrollment of Rare Disease Patients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...